References
- Sharami SRY, Saffarieh E. A review on management of gestational trophoblastic neoplasia. J Fam Med Prim Care. 2020; 9: 1287–95.
- Ozalp SS, Oge T. Gestational trophoblastic diseases in Turkey. J Reprod Med. 2013; 58: 67–71.
- Ozalp SS, Telli E, Oge T, Tulunay G, Boran N, Turan T, et al. Multicenter analysis of gestational trophoblastic neoplasia in Turkey. Asian Pac J Cancer Prev. 2014; 15: 3625–8.
- Eagles N, Sebire NJ, Short D, Savage PM, Seckl MJ, Fisher RA. Risk of recurrent molar pregnancies following complete and partial hydatidiform moles. Hum Reprod. 2015; 30: 2055–63.
- Fisher RA, Maher GJ. Genetics of gestational trophoblastic disease. Best Pract Res Clin Obstet Gynaecol. 2021; 74: 29–41.
- Kalogiannidis I, Kalinderi K, Kalinderis M, Miliaras D, Tarlatzis B, Athanasiadis A. Recurrent complete hydatidiform mole: where we are, is there a safe gestational horizon? Opinion and mini-review. J Assist Reprod Genet. 2018; 35: 967–73.
- McKusick-Nathans Institute of Genetic Medicine. Online Mendelian Inheritance in Man, OMIM®. Johns Hopkins Univ (Baltimore, MD). October 2022 (https://www.omim.org/).
- Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17: 405–23.
- Ambani LM, Vaidya RA, Rao CS, Daftary SD, Motashaw ND. Familial occurrence of trophoblastic disease - report of recurrent molar pregnancies in sisters in three families. Clin Genet. 1980; 18: 27–9.
- La Vecchia C, Franceschi S, Fasoli M, Mangioni C. Gestational trophoblastic neoplasms in homozygous twins. Obstet Gynecol. 1982; 60: 250–2.
- Reddy R, Nguyen NMP, Sarrabay G, Rezaei M, Rivas MCG, Kavasoglu A, et al. The genomic architecture of NLRP7 is Alu rich and predisposes to disease-associated large deletions. Eur J Hum Genet. 2016; 24: 1445–52.
- El-Maarri O, Seoud M, Coullin P, Herbiniaux U, Oldenburg J, Rouleau G, et al. Maternal alleles acquiring paternal methylation patterns in biparental complete hydatidiform moles. Hum Mol Genet. 2003; 12: 1405–13.
- Hashimoto K, Azuma C, Koyama M, Ohashi K, Kamiura S, Nobunaga T, et al. Loss of imprinting in choriocarcinoma. Nat Genet. 1995; 9: 109–10.
- Murdoch S, Djuric U, Mazhar B, Seoud M, Khan R, Kuick R, et al. Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat Genet. 2006; 38: 300–2.
- Nguyen NMP, Khawajkie Y, Mechtouf N, Rezaei M, Breguet M, Kurvinen E, et al. The genetics of recurrent hydatidiform moles: new insights and lessons from a comprehensive analysis of 113 patients. Mod Pathol. 2018; 31: 1116–30.
- Slim R, Fisher R, Milhavet F, Hemida R, Rojas S, Rittore C, et al. Biallelic NLRP7 variants in patients with recurrent hydatidiform mole: A review and expert consensus. Hum Mutat. 2022; 1-13.
- Ulker V, Gurkan H, Tozkir H, Karaman V, Ozgur H, Numanoglu C, et al. Novel NLRP7 mutations in familial recurrent hydatidiform mole: are NLRP7 mutations a risk for recurrent reproductive wastage? Eur J Obstet Gynecol Reprod Biol. 2013; 170: 188–92.
- Buyukkurt S, Fisher RA, Vardar MA, Evruke C. Heterogeneity in recurrent complete hydatidiform mole: presentation of two new Turkish families with different genetic characteristics. Placenta. 2010; 31: 1023–5.